Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross J Simpson

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Pharmacoepidemiology and Drug Safety|June 27, 2018
Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugsMugdha Gokhale, John B Buse, Christina DeFilippo Mack, et al.
BMC Cardiovascular Disorders|August 20, 2004
Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional studyMark W Massing, Kathleen A Foley, Lori Carter-Edwards, et al.
Pharmacoepidemiology and Drug Safety|April 15, 2018
Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approachesMitchell M Conover, Til Stürmer, Charles Poole, et al.
The American Journal of Cardiology|September 28, 2011
Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study)Sunil K Agarwal, Ross J Simpson, Pentti Rautaharju, et al.
Pharmacoepidemiology and Drug Safety|February 7, 2018
Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities studyMontika Bush, Til Stürmer, Sally C Stearns, et al.
Journal of Managed Care & Specialty Pharmacy|May 1, 2019
Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort StudyTitus Schleyer, Siu Hui, Jane Wang, et al.
The American Journal of Cardiology|January 1, 2013
Effect of statin use on acute kidney injury risk following coronary artery bypass graftingJ Bradley Layton, Abhijit V Kshirsagar, Ross J Simpson, et al.
Diabetes Care|December 24, 2004
Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care settingShoko Maru, Gary G Koch, Monika Stender, et al.
Pharmacoepidemiology and Drug Safety|August 21, 2013
Acute kidney injury in statin initiatorsJ Bradley Layton, M Alan Brookhart, Michele Jonsson Funk, et al.
Lipids in Health and Disease|May 20, 2015
Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based surveyMichel Krempf, Ross J Simpson, Dena Rosen Ramey, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Pharmacoepidemiology and Drug Safety|June 27, 2018
Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugsMugdha Gokhale, John B Buse, Christina DeFilippo Mack, et al.
BMC Cardiovascular Disorders|August 20, 2004
Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional studyMark W Massing, Kathleen A Foley, Lori Carter-Edwards, et al.
Pharmacoepidemiology and Drug Safety|April 15, 2018
Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approachesMitchell M Conover, Til Stürmer, Charles Poole, et al.
The American Journal of Cardiology|September 28, 2011
Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study)Sunil K Agarwal, Ross J Simpson, Pentti Rautaharju, et al.
Pharmacoepidemiology and Drug Safety|February 7, 2018
Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities studyMontika Bush, Til Stürmer, Sally C Stearns, et al.
Journal of Managed Care & Specialty Pharmacy|May 1, 2019
Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort StudyTitus Schleyer, Siu Hui, Jane Wang, et al.
The American Journal of Cardiology|January 1, 2013
Effect of statin use on acute kidney injury risk following coronary artery bypass graftingJ Bradley Layton, Abhijit V Kshirsagar, Ross J Simpson, et al.
Diabetes Care|December 24, 2004
Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care settingShoko Maru, Gary G Koch, Monika Stender, et al.
Pharmacoepidemiology and Drug Safety|August 21, 2013
Acute kidney injury in statin initiatorsJ Bradley Layton, M Alan Brookhart, Michele Jonsson Funk, et al.
Lipids in Health and Disease|May 20, 2015
Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based surveyMichel Krempf, Ross J Simpson, Dena Rosen Ramey, et al.
Pageof 11